Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 09, 2011 17:01 ET | Source: Immune Pharmaceuticals Inc

EpiCept to Report Second Quarter 2011 Operating Highlights and Financial Results on August 15, 2011

EpiCept to Report Second Quarter 2011 Operating Highlights and Financial Results on August 15, 2011 TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept...
July 18, 2011 00:01 ET | Source: Immune Pharmaceuticals Inc

EpiCept Corporation Announces Publication in Journal Blood of a New Meta-Analysis Examining Lack of Efficacy of Interleukin-2 ....

EpiCept Corporation Announces Publication in Journal Blood of a New Meta-Analysis Examining Lack of Efficacy of Interleukin-2 .... Meta-Analysis of Six International Randomized AML Trials Clearly...
June 28, 2011 18:07 ET | Source: Immune Pharmaceuticals Inc

EpiCept Corporation Announces Reconvened Stockholders' Meeting Results

EpiCept Corporation Announces Reconvened Stockholders' Meeting Results TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq and Nasdaq...
June 27, 2011 00:19 ET | Source: Immune Pharmaceuticals Inc

EpiCept Receives Initial FDA Comments on Application for Ceplene® Special Protocol Assessment

EpiCept Receives Initial FDA Comments on Application for Ceplene® Special Protocol Assessment TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept...
June 22, 2011 18:02 ET | Source: Immune Pharmaceuticals Inc

EpiCept Announces Webcast of Annual Shareholder Meeting

EpiCept Announces Webcast of Annual Shareholder Meeting TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm...
June 22, 2011 00:01 ET | Source: Immune Pharmaceuticals Inc

EpiCept Seeks Primary Listing Status on OMX Stockholm Exchange

EpiCept Seeks Primary Listing Status on OMX Stockholm Exchange TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq and Nasdaq OMX...
June 20, 2011 00:01 ET | Source: Immune Pharmaceuticals Inc

EpiCept Corporation Announces Stockholders' Meeting Results and Adjournment

EpiCept Corporation Announces Stockholders' Meeting Results and Adjournment TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq and...
June 16, 2011 21:00 ET | Source: Immune Pharmaceuticals Inc

EpiCept Announces Resignation of Board Member

EpiCept Announces Resignation of Board Member TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange:...
June 13, 2011 17:05 ET | Source: Immune Pharmaceuticals Inc

EpiCept to Present at the 5th Lippert/Heilshorn Life Sciences & Medical Technologies Virtual Conference on June 16

EpiCept to Present at the 5th Lippert/Heilshorn Life Sciences & Medical Technologies Virtual Conference on June 16 TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory...
June 07, 2011 00:01 ET | Source: Immune Pharmaceuticals Inc

EpiCept Receives Positive Nasdaq Panel Decision

EpiCept Receives Positive Nasdaq Panel Decision TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm Exchange:...